Read on to learn about the medications used to manage PCOS symptoms.

Some drug therapies can regulate hormones to restore a normalmenstrual cycle.

There are medications that can improve the chances of getting pregnant for those experiencing infertility.

Woman discussing product with pharmacist in drugstore

Dan Dalton / Getty Images

these treatments are used either alone or in combination.

In addition to exercise and diet, drug therapies are sometimes used to assist with weight loss.

Hyperandrogenism

Women with PCOS often have elevated levels of male hormones (androgens), includingtestosterone.

Hyperandrogenism is commonly treated with drugs that either block androgen production or counteract the effects of abnormal hair growth.

These include:

In addition to changes in hair growth, hyperandrogenism can lead to the development of acne.

PCOS-induced acne is typically treated with topical preparations such asbenzoyl peroxide,salicylic acid,retinoids, orantibiotics.

Your healthcare provider may offer these recommendations as a first-line intervention before prescribing medication.

This may include agynecologist, anendocrinologist, or a fertility specialist known as a reproductive endocrinologist.

These include Clomid (clomiphene citrate), Femara (letrozole), and Glucophage (metformin).

Weight loss medications may help with regulating ovulation in PCOS patients who are overweight or obese.

It may be an option if you have PCOS and a BMI of 35 or more.

Legro RS.Evaluation and treatment of polycystic ovary syndrome.

Bahamondes L, Valeria Bahamondes M, Shulman LP.Non-contraceptive benefits of hormonal and intrauterine reversible contraceptive methods.Hum Reprod Update.

Sawant S, Bhide P.Fertility treatment options for women with polycystic ovary syndrome.Clin Med Insights Reprod Health.

2024 May 17;109(6):1630-1655. doi: 10.1210/clinem/dgad762.

Ibricevic D, Asimi ZV.Frequency of prediabetes in women with polycystic ovary syndrome.Med Arch.

2017;11(2):56-66.

2023 Jul 18;24(1):457. doi: 10.1186/s13063-023-07466-y.

Erratum in: Trials.

2023 Jul 31;24(1):486. doi: 10.1186/s13063-023-07535-2.